Pharmacological management of attention-deficit hyperactivity disorder

Gloria Reeves, Julie B Schweitzer

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Pharmacotherapy is the most common intervention for attention-deficit hyperactivity disorder (ADHD). Stimulant medications are highly efficacious and are the gold-standard for treating the inattention, impulsivity and excessive motoric activity associated with ADHD. Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules. Several nonstimulant, second-line treatments are now available or under development for the treatment of ADHD in children and adults. This article reviews the support for a variety of pharmacological agents and the issues to be considered when selecting an agent. The authors conclude that there is a need for additional direct comparisons between the longer-acting agents to effectively guide the practicing clinician. 2004

Original languageEnglish (US)
Pages (from-to)1313-1320
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Issue number6
StatePublished - Jun 2004
Externally publishedYes


  • Attention deficit hyperactivity disorder
  • Drug treatment
  • Nonstimulant
  • Side effects
  • Stimulant

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Pharmacological management of attention-deficit hyperactivity disorder'. Together they form a unique fingerprint.

Cite this